Impacts on Histological Features and (11)C-Methyl-L-methionine Uptake After “One-Shot” Administration with Bevacizumab Before Surgery in Newly Diagnosed Glioblastoma()

BACKGROUND: Bevacizumab (BEV), an antiangiogenic agent, induces dramatic normalization of the tumor vasculature in glioblastoma. This study aimed to clarify how one-time administration of BEV changes histological features in glioblastoma and how histological changes affect the uptake of (11)C-methyl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Beppu, Takaaki, Sato, Yuichi, Yamada, Noriyuki, Terasaki, Kazunori, Sasaki, Toshiaki, Sugai, Tamotsu, Ogasawara, Kuniaki
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2019
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717056/
https://ncbi.nlm.nih.gov/pubmed/31446307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.08.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars